
7. Prescribing Cancer Therapies: Guidelines and Workflow for the Advanced Practitioner
Outline:
- Regulatory Requirements for Prescribing Antineoplastic Therapy
- Investigational Therapy Prescribing
- Basic Principles of Safety for Prescribing Antineoplastic Agents
- Assessment Prior to Prescribing a New Regimen
- Assessment Prior to Subsequent Cycles or Doses
After completing this educational activity, participants should be able to:
- Describe national, state, and institutional regulatory guidelines for prescribing antineoplastic agents
- Identify available resources to guide safe prescribing practices for standard therapies or investigational agents
- Apply key elements of a comprehensive process for patient assessment prior to prescribing antineoplastic therapies that is tailored to the individual patient
- Analyze individual practices for gaps in workflow or resources to facilitate practice improvement for expanded role of the AP in prescribing antineoplastic agents
Sandra Kurtin
PhD, ANP-BC, FAPO
The University of Arizona Cancer Center
Dr. Sandra Kurtin received her BS and MS in oncology nursing, post-graduate certification in geriatric and adult practice, and, most recently, her PhD in nursing at the University of Arizona. She has been an Assistant Professor of Clinical Medicine and Adjunct Clinical Assistant Professor of Nursing at The University of Arizona College of Medicine since 2014. She is currently the Director of Advanced Practice and a Hematology/Oncology Nurse Practitioner at The University of Arizona Cancer Center where she has practiced for 40 years, 32 of those in advanced practice.
Sandra is honored to be a founding board member of APSHO and an inaugural Fellow of Advanced Practice in Oncology (FAPO). She is an active member of ASH and ASCO. In addition, she is a member of the executive committee and board of directors and co-chair of the Nursing Leadership Board for the MDS Foundation.
Sandra has been an associate editor for the Journal of the Advanced Practitioner in Oncology (JADPRO) since its inception, recently transitioning to an editorial board member. She has presented numerous regional, national, and international lectures on oncology-related topics and published numerous articles in peer-reviewed journals, including the New England Journal of Medicine, Cancer Nursing, Clinical Leukemia, Blood, Leukemia Research, JADPRO, Seminars in Oncology Nursing, and the Clinical Journal of Oncology Nursing.
Key:




